| Symbol |
Name |
|
ABCB5
|
ATP-binding cassette, sub-family B (MDR/TAP), member 5
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACTN2
|
actinin, alpha 2
|
|
ADCYAP1
|
adenylate cyclase activating polypeptide 1 (pituitary)
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADORA1
|
adenosine A1 receptor
|
|
ADRB1
|
adrenoceptor beta 1
|
|
AKAP6
|
A kinase (PRKA) anchor protein 6
|
|
AKAP9
|
A kinase (PRKA) anchor protein 9
|
|
ANK2
|
ankyrin 2, neuronal
|
|
ANK3
|
ankyrin 3, node of Ranvier (ankyrin G)
|
|
ANO1
|
anoctamin 1, calcium activated chloride channel
|
|
ARL6IP5
|
ADP-ribosylation factor-like 6 interacting protein 5
|
|
ASIC2
|
acid sensing (proton gated) ion channel 2
|
|
ATP1A1
|
ATPase, Na+/K+ transporting, alpha 1 polypeptide
|
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide
|
|
ATP1A4
|
ATPase, Na+/K+ transporting, alpha 4 polypeptide
|
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide
|
|
ATP1B2
|
ATPase, Na+/K+ transporting, beta 2 polypeptide
|
|
ATP1B3
|
ATPase, Na+/K+ transporting, beta 3 polypeptide
|
|
ATP2A2
|
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
|
|
ATPIF1
|
ATPase inhibitory factor 1
|
|
ATXN1
|
ataxin 1
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCO2
|
beta-carotene oxygenase 2
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BEST2
|
bestrophin 2
|
|
BNIP3
|
BCL2/adenovirus E1B 19kDa interacting protein 3
|
|
BVES
|
blood vessel epicardial substance
|
|
C15ORF27
|
chromosome 15 open reading frame 27
|
|
C22ORF29
|
chromosome 22 open reading frame 29
|
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
|
|
CACNA1B
|
calcium channel, voltage-dependent, N type, alpha 1B subunit
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CACNA1D
|
calcium channel, voltage-dependent, L type, alpha 1D subunit
|
|
CACNA1E
|
calcium channel, voltage-dependent, R type, alpha 1E subunit
|
|
CACNA1F
|
calcium channel, voltage-dependent, L type, alpha 1F subunit
|
|
CACNA1G
|
calcium channel, voltage-dependent, T type, alpha 1G subunit
|
|
CACNA1H
|
calcium channel, voltage-dependent, T type, alpha 1H subunit
|
|
CACNA1I
|
calcium channel, voltage-dependent, T type, alpha 1I subunit
|
|
CACNA1S
|
calcium channel, voltage-dependent, L type, alpha 1S subunit
|
|
CACNB3
|
calcium channel, voltage-dependent, beta 3 subunit
|
|
CACNB4
|
calcium channel, voltage-dependent, beta 4 subunit
|
|
CACNG2
|
calcium channel, voltage-dependent, gamma subunit 2
|
|
CACNG4
|
calcium channel, voltage-dependent, gamma subunit 4
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CASQ2
|
calsequestrin 2 (cardiac muscle)
|
|
CATSPER1
|
cation channel, sperm associated 1
|
|
CATSPER2
|
cation channel, sperm associated 2
|
|
CATSPER3
|
cation channel, sperm associated 3
|
|
CATSPER4
|
cation channel, sperm associated 4
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CAV3
|
caveolin 3
|
|
CDK5
|
cyclin-dependent kinase 5
|
|
CELF4
|
CUGBP, Elav-like family member 4
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHRNA1
|
cholinergic receptor, nicotinic, alpha 1 (muscle)
|
|
CHRNA3
|
cholinergic receptor, nicotinic, alpha 3 (neuronal)
|
|
CHRNA4
|
cholinergic receptor, nicotinic, alpha 4 (neuronal)
|
|
CHRNA6
|
cholinergic receptor, nicotinic, alpha 6 (neuronal)
|
|
CHRNB1
|
cholinergic receptor, nicotinic, beta 1 (muscle)
|
|
CHRNB2
|
cholinergic receptor, nicotinic, beta 2 (neuronal)
|
|
CHRNB4
|
cholinergic receptor, nicotinic, beta 4 (neuronal)
|
|
CHRND
|
cholinergic receptor, nicotinic, delta (muscle)
|
|
CHRNE
|
cholinergic receptor, nicotinic, epsilon (muscle)
|
|
CHRNG
|
cholinergic receptor, nicotinic, gamma (muscle)
|
|
CLIC1
|
chloride intracellular channel 1
|
|
CLN3
|
ceroid-lipofuscinosis, neuronal 3
|
|
CNGA1
|
cyclic nucleotide gated channel alpha 1
|
|
CNGA2
|
cyclic nucleotide gated channel alpha 2
|
|
CNGA3
|
cyclic nucleotide gated channel alpha 3
|
|
CNGA4
|
cyclic nucleotide gated channel alpha 4
|
|
CNGB1
|
cyclic nucleotide gated channel beta 1
|
|
CNGB3
|
cyclic nucleotide gated channel beta 3
|
|
CNIH2
|
cornichon family AMPA receptor auxiliary protein 2
|
|
CNIH3
|
cornichon family AMPA receptor auxiliary protein 3
|
|
CRTC1
|
CREB regulated transcription coactivator 1
|
|
CUX2
|
cut-like homeobox 2
|
|
DLD
|
dihydrolipoamide dehydrogenase
|
|
DLG1
|
discs, large homolog 1 (Drosophila)
|
|
DLG4
|
discs, large homolog 4 (Drosophila)
|
|
DMD
|
dystrophin
|
|
DPP6
|
dipeptidyl-peptidase 6
|
|
DRD1
|
dopamine receptor D1
|
|
DRD4
|
dopamine receptor D4
|
|
EDN1
|
endothelin 1
|
|
EHD3
|
EH-domain containing 3
|
|
FAM19A4
|
family with sequence similarity 19 (chemokine (C-C motif)-like), member A4
|
|
FGF12
|
fibroblast growth factor 12
|
|
FXYD1
|
FXYD domain containing ion transport regulator 1
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJA5
|
gap junction protein, alpha 5, 40kDa
|
|
GJC1
|
gap junction protein, gamma 1, 45kDa
|
|
GJD2
|
gap junction protein, delta 2, 36kDa
|
|
GLRA1
|
glycine receptor, alpha 1
|
|
GLRB
|
glycine receptor, beta
|
|
GLRX
|
glutaredoxin (thioltransferase)
|
|
GNA11
|
guanine nucleotide binding protein (G protein), alpha 11 (Gq class)
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
|
GPD1L
|
glycerol-3-phosphate dehydrogenase 1-like
|
|
GPER1
|
G protein-coupled estrogen receptor 1
|
|
GPR88
|
G protein-coupled receptor 88
|
|
GRID2
|
glutamate receptor, ionotropic, delta 2
|
|
GRIK1
|
glutamate receptor, ionotropic, kainate 1
|
|
GRIK2
|
glutamate receptor, ionotropic, kainate 2
|
|
GRIK3
|
glutamate receptor, ionotropic, kainate 3
|
|
GRIK5
|
glutamate receptor, ionotropic, kainate 5
|
|
GRIN1
|
glutamate receptor, ionotropic, N-methyl D-aspartate 1
|
|
GRIN2A
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A
|
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
|
|
GRIN2C
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2C
|
|
HCN1
|
hyperpolarization activated cyclic nucleotide gated potassium channel 1
|
|
HCN2
|
hyperpolarization activated cyclic nucleotide gated potassium channel 2
|
|
HCN3
|
hyperpolarization activated cyclic nucleotide gated potassium channel 3
|
|
HCN4
|
hyperpolarization activated cyclic nucleotide gated potassium channel 4
|
|
HCRT
|
hypocretin (orexin) neuropeptide precursor
|
|
HEBP2
|
heme binding protein 2
|
|
HTT
|
huntingtin
|
|
IGSF9B
|
immunoglobulin superfamily, member 9B
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
JUN
|
jun proto-oncogene
|
|
KCNA1
|
potassium channel, voltage gated shaker related subfamily A, member 1
|
|
KCNA2
|
potassium channel, voltage gated shaker related subfamily A, member 2
|
|
KCNA5
|
potassium channel, voltage gated shaker related subfamily A, member 5
|
|
KCNC2
|
potassium channel, voltage gated Shaw related subfamily C, member 2
|
|
KCND2
|
potassium channel, voltage gated Shal related subfamily D, member 2
|
|
KCND3
|
potassium channel, voltage gated Shal related subfamily D, member 3
|
|
KCNE1
|
potassium channel, voltage gated subfamily E regulatory beta subunit 1
|
|
KCNE2
|
potassium channel, voltage gated subfamily E regulatory beta subunit 2
|
|
KCNE3
|
potassium channel, voltage gated subfamily E regulatory beta subunit 3
|
|
KCNE5
|
potassium channel, voltage gated subfamily E regulatory beta subunit 5
|
|
KCNH1
|
potassium channel, voltage gated eag related subfamily H, member 1
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNH3
|
potassium channel, voltage gated eag related subfamily H, member 3
|
|
KCNH4
|
potassium channel, voltage gated eag related subfamily H, member 4
|
|
KCNH5
|
potassium channel, voltage gated eag related subfamily H, member 5
|
|
KCNH6
|
potassium channel, voltage gated eag related subfamily H, member 6
|
|
KCNH7
|
potassium channel, voltage gated eag related subfamily H, member 7
|
|
KCNH8
|
potassium channel, voltage gated eag related subfamily H, member 8
|
|
KCNIP2
|
Kv channel interacting protein 2
|
|
KCNJ10
|
potassium channel, inwardly rectifying subfamily J, member 10
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KCNJ2
|
potassium channel, inwardly rectifying subfamily J, member 2
|
|
KCNK1
|
potassium channel, two pore domain subfamily K, member 1
|
|
KCNK10
|
potassium channel, two pore domain subfamily K, member 10
|
|
KCNK12
|
potassium channel, two pore domain subfamily K, member 12
|
|
KCNK13
|
potassium channel, two pore domain subfamily K, member 13
|
|
KCNK15
|
potassium channel, two pore domain subfamily K, member 15
|
|
KCNK16
|
potassium channel, two pore domain subfamily K, member 16
|
|
KCNK17
|
potassium channel, two pore domain subfamily K, member 17
|
|
KCNK18
|
potassium channel, two pore domain subfamily K, member 18
|
|
KCNK2
|
potassium channel, two pore domain subfamily K, member 2
|
|
KCNK3
|
potassium channel, two pore domain subfamily K, member 3
|
|
KCNK4
|
potassium channel, two pore domain subfamily K, member 4
|
|
KCNK5
|
potassium channel, two pore domain subfamily K, member 5
|
|
KCNK6
|
potassium channel, two pore domain subfamily K, member 6
|
|
KCNK7
|
potassium channel, two pore domain subfamily K, member 7
|
|
KCNK9
|
potassium channel, two pore domain subfamily K, member 9
|
|
KCNMA1
|
potassium channel, calcium activated large conductance subfamily M alpha, member 1
|
|
KCNMB2
|
potassium channel subfamily M regulatory beta subunit 2
|
|
KCNMB3
|
potassium channel subfamily M regulatory beta subunit 3
|
|
KCNMB4
|
potassium channel subfamily M regulatory beta subunit 4
|
|
KCNN4
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KCNQ3
|
potassium channel, voltage gated KQT-like subfamily Q, member 3
|
|
KIF5B
|
kinesin family member 5B
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
MAPK8IP2
|
mitogen-activated protein kinase 8 interacting protein 2
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MEF2C
|
myocyte enhancer factor 2C
|
|
MTMR2
|
myotubularin related protein 2
|
|
MYH14
|
myosin, heavy chain 14, non-muscle
|
|
NALCN
|
sodium leak channel, non selective
|
|
NDUFS1
|
NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75kDa (NADH-coenzyme Q reductase)
|
|
NEDD4
|
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase
|
|
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase
|
|
NETO1
|
neuropilin (NRP) and tolloid (TLL)-like 1
|
|
NLGN1
|
neuroligin 1
|
|
NLGN2
|
neuroligin 2
|
|
NLGN3
|
neuroligin 3
|
|
NLGN4X
|
neuroligin 4, X-linked
|
|
NOS1AP
|
nitric oxide synthase 1 (neuronal) adaptor protein
|
|
NPFF
|
neuropeptide FF-amide peptide precursor
|
|
NPPA
|
natriuretic peptide A
|
|
NPY2R
|
neuropeptide Y receptor Y2
|
|
NRXN1
|
neurexin 1
|
|
NTSR2
|
neurotensin receptor 2
|
|
NUP155
|
nucleoporin 155kDa
|
|
OPRD1
|
opioid receptor, delta 1
|
|
OPRM1
|
opioid receptor, mu 1
|
|
P2RX1
|
purinergic receptor P2X, ligand gated ion channel, 1
|
|
P2RX2
|
purinergic receptor P2X, ligand gated ion channel, 2
|
|
P2RX3
|
purinergic receptor P2X, ligand gated ion channel, 3
|
|
P2RX4
|
purinergic receptor P2X, ligand gated ion channel, 4
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
PANK2
|
pantothenate kinase 2
|
|
PARK7
|
parkinson protein 7
|
|
PEX5L
|
peroxisomal biogenesis factor 5-like
|
|
PIAS3
|
protein inhibitor of activated STAT, 3
|
|
PID1
|
phosphotyrosine interaction domain containing 1
|
|
PIEZO1
|
piezo-type mechanosensitive ion channel component 1
|
|
PIEZO2
|
piezo-type mechanosensitive ion channel component 2
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PKP2
|
plakophilin 2
|
|
PLN
|
phospholamban
|
|
PMAIP1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
|
POPDC2
|
popeye domain containing 2
|
|
POPDC3
|
popeye domain containing 3
|
|
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme
|
|
PRDX3
|
peroxiredoxin 3
|
|
PRELID1
|
PRELI domain containing 1
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PSEN1
|
presenilin 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PYCR1
|
pyrroline-5-carboxylate reductase 1
|
|
RAB3GAP1
|
RAB3 GTPase activating protein subunit 1 (catalytic)
|
|
RANGRF
|
RAN guanine nucleotide release factor
|
|
RELN
|
reelin
|
|
RIMS1
|
regulating synaptic membrane exocytosis 1
|
|
RIMS2
|
regulating synaptic membrane exocytosis 2
|
|
RIMS3
|
regulating synaptic membrane exocytosis 3
|
|
RIMS4
|
regulating synaptic membrane exocytosis 4
|
|
RNF207
|
ring finger protein 207
|
|
RYR2
|
ryanodine receptor 2 (cardiac)
|
|
S1PR2
|
sphingosine-1-phosphate receptor 2
|
|
SCN10A
|
sodium channel, voltage gated, type X alpha subunit
|
|
SCN11A
|
sodium channel, voltage gated, type XI alpha subunit
|
|
SCN1A
|
sodium channel, voltage gated, type I alpha subunit
|
|
SCN1B
|
sodium channel, voltage gated, type I beta subunit
|
|
SCN2A
|
sodium channel, voltage gated, type II alpha subunit
|
|
SCN2B
|
sodium channel, voltage gated, type II beta subunit
|
|
SCN3A
|
sodium channel, voltage gated, type III alpha subunit
|
|
SCN3B
|
sodium channel, voltage gated, type III beta subunit
|
|
SCN4A
|
sodium channel, voltage gated, type IV alpha subunit
|
|
SCN4B
|
sodium channel, voltage gated, type IV beta subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SCN7A
|
sodium channel, voltage gated, type VII alpha subunit
|
|
SCN8A
|
sodium channel, voltage gated, type VIII alpha subunit
|
|
SCN9A
|
sodium channel, voltage gated, type IX alpha subunit
|
|
SEZ6
|
seizure related 6 homolog (mouse)
|
|
SHANK1
|
SH3 and multiple ankyrin repeat domains 1
|
|
SHANK3
|
SH3 and multiple ankyrin repeat domains 3
|
|
SLC17A7
|
solute carrier family 17 (vesicular glutamate transporter), member 7
|
|
SLC1A6
|
solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6
|
|
SLC25A27
|
solute carrier family 25, member 27
|
|
SLC25A33
|
solute carrier family 25 (pyrimidine nucleotide carrier), member 33
|
|
SLC25A36
|
solute carrier family 25 (pyrimidine nucleotide carrier), member 36
|
|
SLC26A3
|
solute carrier family 26 (anion exchanger), member 3
|
|
SLC26A5
|
solute carrier family 26 (anion exchanger), member 5
|
|
SLC29A1
|
solute carrier family 29 (equilibrative nucleoside transporter), member 1
|
|
SLC34A1
|
solute carrier family 34 (type II sodium/phosphate cotransporter), member 1
|
|
SLC8A1
|
solute carrier family 8 (sodium/calcium exchanger), member 1
|
|
SLC8B1
|
solute carrier family 8 (sodium/lithium/calcium exchanger), member B1
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNTA1
|
syntrophin, alpha 1
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SPG20
|
spastic paraplegia 20 (Troyer syndrome)
|
|
SRI
|
sorcin
|
|
STOML2
|
stomatin (EPB72)-like 2
|
|
STX1A
|
syntaxin 1A (brain)
|
|
STX1B
|
syntaxin 1B
|
|
TPCN1
|
two pore segment channel 1
|
|
TPCN2
|
two pore segment channel 2
|
|
TRDN
|
triadin
|
|
TRPM4
|
transient receptor potential cation channel, subfamily M, member 4
|
|
TUSC2
|
tumor suppressor candidate 2
|
|
UBB
|
ubiquitin B
|
|
UCN3
|
urocortin 3
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
UNC13B
|
unc-13 homolog B (C. elegans)
|
|
WWP2
|
WW domain containing E3 ubiquitin protein ligase 2
|
|
XIRP1
|
xin actin binding repeat containing 1
|
|
YWHAE
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon
|
|
YWHAH
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta
|